Resources · Insights
Case Studies

Biomaterials
Toll versus Build
Cost Reduction Plan
Biocement Cost Reduction Plan
Roebling built a techno-economic model and a step-by-step cost reduction plan that showed which process, scale, and commercial changes would bring the product to its target cost.
Read now

Biomanufacturing
FEL-1
AACE Class 5-4
Cambrium
Cambrium produces NovaColl, a bio-identical human collagen for skin care, through precision fermentation. Cambrium set out to own its manufacturing economics on every route to scale. Roebling built its contract manufacturer's cost structure alongside Cambrium's greenfield option in one model, giving Cambrium a bottom-up view of both before it decides where to commit capital.
Read now

Healthy Fats & Oils
Business Model & Scale-Up Plan
FEL-2
AACE Class 4
Checkerspot Biosciences
Checkerspot develops healthy fats and oils using microalgae and precision fermentation. Under a Planning Phase Award from the Defense Industrial Base Consortium, Roebling served as its engineering partner from the techno-economic model through a 90+ site search to an FEL-2 package. That work helped Checkerspot move to a capital-light model built on partnerships.
Read now

Food Ingredients
Competitive Benchmark
Techno-Economic Analysis
Competitor Cost Benchmark
A food ingredients company competes with a rival technology that makes the same product. The rival's costs are not public. In four weeks, Roebling built an engineering-based model of the rival process in the U.S. Midwest and in China, with tariffs and shipping included, resulting in an independent cost basis across 80+ scenarios and a ranked view of what drives the competitor's cost.
Read now

Cell-Free Bulk Chemicals
Techno-Economic Analysis
Early Feasibility
Decycle
Decycle is developing a cell-free process to make a commodity bulk chemical. Roebling's integrated techno-economic model gave Decycle a clear no-go on its first route early in the build, then carried a second route through a full facility model that now sets its scale-up targets.
Read now

Biomanufacturing
Cost & Sensitivity Analysis
AACE Class 5-4
EVERY
EVERY makes egg proteins by precision fermentation and already produces at commercial scale. Roebling is building greenfield models of EVERY's current and next-generation processes, so the team can run cost and sensitivity analysis on a greenfield build and on current and potential production sites.
Read now

Cell-Free Biomanufacturing
Process Route & Design Basis
FEL-1
AACE Class 5-4
eXoZymes
eXoZymes pioneers AI-enhanced, cell-free biomanufacturing, using engineered enzyme cascades outside living cells to transform widely available feedstocks into high-value nutraceuticals, potential medicines, and other valuable compounds. Roebling modeled the economics and environmental footprint of a continuous manufacturing process and translated the findings into a FEL-1+ engineering design basis.
Read now

Alternative Protein
Gas Fermentation
FOAK vs. Nth Plant
Gas Fermentation FOAK vs. Nth Plant
Gas fermentation uses bacteria to turn gases into single cell protein for human food. Roebling was hired to study two routes, one fed by methane and one by CO2 and hydrogen. In seven weeks, Roebling modeled both on one design basis, resulting in an independent view of what a first-of-a-kind plant and an nth plant would cost to build and run, and how long each would take to bring online.
Read now

Biomanufacturing
AACE Class 5-4
FEL-1
Helaina
Helaina uses precision fermentation to make effera®, the world's first bio-identical human lactoferrin, now produced at metric-ton scale. Working with Roebling engineers, the Helaina team built a live, fully costed model of that production in their own workspace. Now they can test their scale-up options themselves instead of commissioning a study.
Read now

Microbial Protein
Aquafeed
Feasibility & Financing
Microbial Protein for Aquafeed
A microbial protein company had proven its aquafeed ingredient at demonstration scale and was raising capital for a commercial facility. In about two months, Roebling built a techno-economic model and a project finance model, resulting in an independent view of commercial cost, the minimum price and scale for a financeable plant, and the best place to build it.
Read now

Single Cell Protein
Build versus Lease
AACE Class 4
Proteo
Proteo makes single cell protein from yeast by continuous fermentation, for human and animal nutrition. In about six weeks, Roebling built a techno-economic model of its process, resulting in a scale-up plan that showed the smallest facility to meet its price target and whether to build new or lease existing space.
Read now

Biomanufacturing
FEL-1
Site Selection
AACE Class 5-4
TurtleTree
TurtleTree produces lactoferrin through precision fermentation. Roebling built an integrated techno-economic model of the process and used it to run TurtleTree's site selection, product and technology trade-offs, and buy-vs-build economics through to a fundable FEL-1 design basis, without switching tools or re-deriving the cost basis at each stage.
Read now

Precision Fermentation
Toll versus Build
AACE Class 4
Zya
Zya makes enzymes by precision fermentation. Roebling built a working techno-economic model that gave Zya a scale-up plan, from tolling at a contract manufacturer to the point where building its own capacity makes sense.
Read now
We value your privacy
We use cookies to improve site functionality. Some cookies help us understand how visitors use our site.
